Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish

Psychopharmacology (Berl). 2012 Mar;220(2):319-30. doi: 10.1007/s00213-011-2482-2. Epub 2011 Sep 29.

Abstract

Rationale: Oxytocin (OT) and arginine-vasopressin (AVP) regulate social behavior in mammals. Zebrafish (Danio rerio) allows higher throughput and ease in studying human brain disorders.

Objectives: This study investigated in zebrafish the effect of non-mammalian homologs isotocin (IT) and vasotocin (AVT) in comparison with OT/AVP on social behavior and fear response to predator. The mechanism was studied using the most human selective OT and AVP receptor antagonists.

Methods: Zebrafish were injected i.m. with increasing doses (0.001-40 ng/kg) of the neuropeptides. DesGly-NH(2)-d(CH(2))(5)-[D-Tyr(2),Thr(4)]OVT) for OT receptor, SR 49059 for V1a subtype receptor, and SSR-149415 for V1b subtype receptor were injected i.m. 10 min before each agonist.

Results: All the peptides increased social preference and reduced fear to predator response in a dose-dependent manner interpolated by symmetrical parabolas. AVT/AVP were more potent to elicit anxiolytic than social effect while IT and OT were equally potent. All the antagonists dose-dependently inhibited both the effects induced by the neuropeptides. The ratio between the ED50 obtained for blocking the OT-induced effects on social preference and fear response to predator was very high only for desglyDTTyrOVT (160). SR49059 showed the highest ratio in blocking AVP-induced effects (807). The less selective antagonist appeared to be SSR149415.

Conclusions: For the first time, IT/AVT and OT/AVP were found to modulate in zebrafish, social behavior, unrelated to sex, and fear to predator response through at least two different receptors. Zebrafish is confirmed as a valid, reliable model to study deficit in social behavior characteristic of some psychiatric disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology*
  • Antidiuretic Hormone Receptor Antagonists
  • Dose-Response Relationship, Drug
  • Fear / drug effects*
  • Indoles / pharmacology
  • Ornipressin / analogs & derivatives
  • Ornipressin / pharmacology
  • Oxytocin / analogs & derivatives
  • Oxytocin / antagonists & inhibitors
  • Oxytocin / pharmacology
  • Oxytocin / physiology*
  • Pituitary Hormones, Posterior / pharmacology
  • Pituitary Hormones, Posterior / physiology
  • Pyrrolidines / pharmacology
  • Radioligand Assay / methods
  • Radioligand Assay / statistics & numerical data
  • Receptors, Oxytocin / antagonists & inhibitors
  • Receptors, Oxytocin / physiology
  • Receptors, Vasopressin / physiology*
  • Social Behavior*
  • Swimming
  • Vasopressins / antagonists & inhibitors
  • Vasopressins / pharmacology
  • Vasopressins / physiology*
  • Vasotocin / antagonists & inhibitors
  • Vasotocin / pharmacology
  • Vasotocin / physiology*
  • Zebrafish

Substances

  • 1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide
  • Anti-Anxiety Agents
  • Antidiuretic Hormone Receptor Antagonists
  • Indoles
  • Pituitary Hormones, Posterior
  • Pyrrolidines
  • Receptors, Oxytocin
  • Receptors, Vasopressin
  • Vasopressins
  • vasotocin, desGly(NH2)(9)d(CH2)5-Tyr(Me)(2)-Thr(4)-Orn(8)-
  • Ornipressin
  • Oxytocin
  • isotocin
  • relcovaptan
  • Vasotocin